Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Davidson Kempner

London - 1.

28.07.2020 - 19:57:14

Davidson Kempner Expects Thermo Fisher Scientific's Current Offer for QIAGEN N.V. to Fail

London -

1. Davidson Kempner European Partners, LLP is the sub-adviser to Davidson Kempner Capital Management LP which acts as the discretionary investment manager to various funds which represent 5.1% of the share capital of QIAGEN N.V. (the "Company") 2. Davidson Kempner believes the standalone fair value for the Company to be EUR48-52 per share 3. Davidson Kempner will not be tendering its shares and fully expects the current offer to fail 4. Davidson Kempner has launched a website containing supporting information and evidence: https://unlockthevalueofqiagen.com/ (https://gbr01.safelinks.protec tion.outlook.com/?url=https%3A%2F%2Funlockthevalueofqiagen.com%2F&data=02%7C0 1%7Ctberezowski%40greenbrookpr.com%7C183d35df526a4b411e9008d83300fa18%7C1b4cd e5a065d44119a0f6e404986a335%7C0%7C0%7C637315426580786197&sdata=XtLRDhnwpWNMjE 8NlimLGAYO2tdDmoJYWGclf5JMxH4%3D&reserved=0)

For media enquiries: Greenbrook Andrew Honnor, Rob White, Fanni Bodri Email: davidsonkempner@greenbrookpr.com Tel: +44 (0) 20 7952-2000

Additional content: http://presseportal.de/pm/146402/4664402 Davidson Kempner

@ presseportal.de